B-cell lymphoma 2 (Bcl-2), a classical anti-apoptosis protein, has been shown to be overexpressed in biopsy specimens from NPC patients, and Bcl-2 is predominately co-expressed with p53 in NPC [17–20]. This evidence concerns the gene TP53 and nasopharyngeal carcinoma.